These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30009503)

  • 1. Exendin-4 enhances radiation response of prostate cancer.
    He W; Li J
    Prostate; 2018 Nov; 78(15):1125-1133. PubMed ID: 30009503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 enhances the sensitivity of prostate cancer to enzalutamide by targeting Akt activation.
    Wenjing H; Shao Y; Yu Y; Huang W; Feng G; Li J
    Prostate; 2020 Apr; 80(5):367-375. PubMed ID: 31967357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate enhances the response of prostate cancer to radiotherapy.
    Broadfield LA; Marcinko K; Tsakiridis E; Zacharidis PG; Villani L; Lally JSV; Menjolian G; Maharaj D; Mathurin T; Smoke M; Farrell T; Muti P; Steinberg GR; Tsakiridis T
    Prostate; 2019 Apr; 79(5):489-497. PubMed ID: 30609074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression.
    Shigeoka T; Nomiyama T; Kawanami T; Hamaguchi Y; Horikawa T; Tanaka T; Irie S; Motonaga R; Hamanoue N; Tanabe M; Nabeshima K; Tanaka M; Yanase T; Kawanami D
    J Diabetes Investig; 2020 Sep; 11(5):1137-1149. PubMed ID: 32146725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer.
    Yue Y; Xu Y; Huang L; Pan D; Bai Z; Wang L; Yang R; Yan J; Song H; Li X; Yang M
    Anticancer Agents Med Chem; 2019; 19(4):509-514. PubMed ID: 30068284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.
    Cao C; Subhawong T; Albert JM; Kim KW; Geng L; Sekhar KR; Gi YJ; Lu B
    Cancer Res; 2006 Oct; 66(20):10040-7. PubMed ID: 17047067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
    Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
    Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts.
    Wu L; Birle DC; Tannock IF
    Cancer Res; 2005 Apr; 65(7):2825-31. PubMed ID: 15805283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice.
    Zhang Y; Xu F; Liang H; Cai M; Wen X; Li X; Weng J
    Oncol Rep; 2016 Mar; 35(3):1340-8. PubMed ID: 26648451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/mTOR pathway in vitro and in vivo.
    Yan Y; Du C; Li G; Chen L; Yan Y; Chen G; Hu W; Chang L
    Urol Oncol; 2018 Jun; 36(6):312.e1-312.e8. PubMed ID: 29566977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth.
    Tsutsumi Y; Nomiyama T; Kawanami T; Hamaguchi Y; Terawaki Y; Tanaka T; Murase K; Motonaga R; Tanabe M; Yanase T
    PLoS One; 2015; 10(10):e0139709. PubMed ID: 26439622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.
    Yu C; Cao H; He X; Sun P; Feng Y; Chen L; Gong H
    Biomed Pharmacother; 2017 Dec; 96():1109-1118. PubMed ID: 29196103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth.
    Nomiyama T; Kawanami T; Irie S; Hamaguchi Y; Terawaki Y; Murase K; Tsutsumi Y; Nagaishi R; Tanabe M; Morinaga H; Tanaka T; Mizoguchi M; Nabeshima K; Tanaka M; Yanase T
    Diabetes; 2014 Nov; 63(11):3891-905. PubMed ID: 24879833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts.
    Storozhuk Y; Sanli T; Hopmans SN; Schultz C; Farrell T; Cutz JC; Steinberg GR; Wright J; Singh G; Tsakiridis T
    Radiat Oncol; 2012 May; 7():71. PubMed ID: 22607554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions.
    Potiron VA; Abderrahmani R; Giang E; Chiavassa S; Di Tomaso E; Maira SM; Paris F; Supiot S
    Radiother Oncol; 2013 Jan; 106(1):138-46. PubMed ID: 23321494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
    Yang F; Song L; Wang H; Wang J; Xu Z; Xing N
    PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study.
    Zerp SF; Vens C; Floot B; Verheij M; van Triest B
    Radiother Oncol; 2014 Feb; 110(2):348-54. PubMed ID: 24412016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent and sequential administration of chemotherapy and the Mammalian target of rapamycin inhibitor temsirolimus in human cancer cells and xenografts.
    Fung AS; Wu L; Tannock IF
    Clin Cancer Res; 2009 Sep; 15(17):5389-95. PubMed ID: 19706800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.